EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis

Naoki Okada, Yoshiro Yamamoto, Tsuyoshi Oguma, Jun Tanaka, Katsuyoshi Tomomatsu, Yoshiki Shiraishi iD, Hiroto Matsuse, Terufumi Shimoda, Hirokazu Kimura, Kentaro Watai, Toshiyuki Harada, Yuka Fujita und 8 weitere

Allergy · 2023-11 · 78 (11) · 2933-2943

DOI: 10.1111/all.15820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, online erschienen am 17.07.2023. Verfasst von Naoki Okada und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan. Hauptthemen laut MEDLINE: Aspergillosis, Allergic Bronchopulmonary, Asthma, Hypersensitivity, Immediate. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergic bronchopulmonary aspergillosis (ABPA) develops in the presence or absence of asthma, either atopic or nonatopic. We have tried to explore the essential components in the pathogenesis of the disease, which are either consistent and variable according to the presence and type of asthma.

Methods

Non‐cystic fibrosis ABPA cases satisfying Asano's criteria were extracted from a prospective registry of ABPA and related diseases in Japan between 2013 and 2023. According to the type of preceding asthma, ABPA was classified into three groups: ABPA sans asthma (no preceding asthma), ABPA with atopic asthma, and ABPA with nonatopic asthma. Exploratory and confirmatory factor analyses were performed to identify the components that determined the clinical characteristics of ABPA.

Results

Among 106 cases of ABPA, 25 patients (24%) had ABPA sans asthma, whereas 57 (54%) and 24 (23%) had ABPA with atopic and nonatopic asthma, respectively. Factor analysis identified three components: allergic, eosinophilic, and fungal. Patients with atopic asthma showed the highest scores for the allergic component ( p < .001), defined by total and allergen‐specific IgE titers and lung opacities, and the lowest scores for the fungal component defined by the presence of specific precipitin/IgG or positive culture for A. fumigatus . Eosinophilic components, including peripheral blood eosinophil counts and presence of mucus plugs/high attenuation mucus in the bronchi, were consistent among the three groups.

Conclusion

The eosinophilic component of ABPA is considered as the cardinal feature of ABPA regardless of the presence of preceding asthma or atopic predisposition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aspergillosis, Allergic BronchopulmonaryAsthmaHypersensitivity, ImmediateHumansImmunoglobulin ELeukocyte Count

Stichwörter der Autor:innen

IgEallergic bronchopulmonary aspergillosiseosinophilsfactor analysisfungal component

Substanzen

Immunoglobulin E

Autor:innen und Institutionen

  • Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan.
  • Department of Mathematics, School of Science, Tokai University, Kanagawa, Japan.
  • Division of Respiratory Medicine, Department of Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
  • Department of Allergy, Clinical Research Center, National Hospital Organization Fukuoka Hospital, Fukuoka, Japan.
  • Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.

ORCID-Profile: Yoshiki Shiraishi, Maho Suzukawa, Koichiro Asano

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Okada, N., Yamamoto, Y., Oguma, T., Tanaka, J., Tomomatsu, K., Shiraishi, Y., Matsuse, H., Shimoda, T., Kimura, H., Watai, K., Harada, T., Fujita, Y., Obase, Y., Suzukawa, M., Suzuki, J., Takayanagi, N., Ishiguro, T., Masaki, K., Fukunaga, K., & Asano, K. (2023). Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis. Allergy, 78(11), 2933-2943. https://doi.org/10.1111/all.15820

Vancouver

Okada N, Yamamoto Y, Oguma T, Tanaka J, Tomomatsu K, Shiraishi Y, et al. Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis. Allergy. 2023;78(11):2933-2943. doi:10.1111/all.15820

BibTeX
@article{Okada2023,
  author = {Okada, Naoki and Yamamoto, Yoshiro and Oguma, Tsuyoshi and Tanaka, Jun and Tomomatsu, Katsuyoshi and Shiraishi, Yoshiki and Matsuse, Hiroto and Shimoda, Terufumi and Kimura, Hirokazu and Watai, Kentaro and Harada, Toshiyuki and Fujita, Yuka and Obase, Yasushi and Suzukawa, Maho and Suzuki, Junko and Takayanagi, Noboru and Ishiguro, Takashi and Masaki, Katsunori and Fukunaga, Koichi and Asano, Koichiro},
  title = {Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis},
  journal = {Allergy},
  year = {2023},
  volume = {78},
  number = {11},
  pages = {2933--2943},
  doi = {10.1111/all.15820}
}
Kostenlos starten →